Christine Bowman

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Topics

Cerebrospinal Fluid

Structure Activity Relationship

Cross Sectional

Top Venues

CPT: pharmacometrics & systems pharmacology

Biopharmaceutics & drug disposition

This page only lists publications with an associated author ORCID identifier.

Publications

Christine Bowman, Michael Dolton, Fang Ma, Sravanthi Cheeti, Denison Kuruvilla, Rucha Sane, Nastya Kassir, Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Christine Bowman, Michael Dolton, Fang Ma, Sravanthi Cheeti, Denison Kuruvilla, Rucha Sane, Nastya Kassir, Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Christine Bowman, Michael Dolton, Fang Ma, Sravanthi Cheeti, Denison Kuruvilla, Rucha Sane, Nastya Kassir, Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Christine Bowman, Michael Dolton, Fang Ma, Sravanthi Cheeti, Denison Kuruvilla, Rucha Sane, Nastya Kassir, Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Christine Bowman, Michael Dolton, Fang Ma, Sravanthi Cheeti, Denison Kuruvilla, Rucha Sane, Nastya Kassir, Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Christine Bowman, Michael Dolton, Fang Ma, Sravanthi Cheeti, Denison Kuruvilla, Rucha Sane, Nastya Kassir, Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Christine Bowman, Michael Dolton, Fang Ma, Sravanthi Cheeti, Denison Kuruvilla, Rucha Sane, Nastya Kassir, Yuan Chen
Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib. CPT: pharmacometrics & systems pharmacology (2024)
Christine Bowman, Fang Ma, Jialin Mao, Emile Plise, Eugene Chen, Liling Liu, Shu Zhang, Yuan Chen
Evaluation of bottom-up modeling of the blood-brain barrier to improve brain penetration prediction via physiologically based pharmacokinetic modeling. Biopharmaceutics & drug disposition 44 (1) (2023)
Christine Bowman, Fang Ma, Jialin Mao, Emile Plise, Eugene Chen, Liling Liu, Shu Zhang, Yuan Chen
Evaluation of bottom-up modeling of the blood-brain barrier to improve brain penetration prediction via physiologically based pharmacokinetic modeling. Biopharmaceutics & drug disposition 44 (1) (2023)
Christine Bowman, Fang Ma, Jialin Mao, Emile Plise, Eugene Chen, Liling Liu, Shu Zhang, Yuan Chen
Evaluation of bottom-up modeling of the blood-brain barrier to improve brain penetration prediction via physiologically based pharmacokinetic modeling. Biopharmaceutics & drug disposition (2023)
Christine Bowman, Fang Ma, Jialin Mao, Emile Plise, Eugene Chen, Liling Liu, Shu Zhang, Yuan Chen
Evaluation of bottom-up modeling of the blood-brain barrier to improve brain penetration prediction via physiologically based pharmacokinetic modeling. Biopharmaceutics & drug disposition 44 (1) (2023)
Jialin Mao, Fang Ma, Jesse Yu, Tom De Bruyn, Miaoran Ning, Christine Bowman, Yuan Chen
Shared learning from a physiologically based pharmacokinetic modeling strategy for human pharmacokinetics prediction through retrospective analysis of Genentech compounds. Biopharmaceutics & drug disposition (2023)
Christine Bowman, Fang Ma, Jialin Mao, Emile Plise, Eugene Chen, Liling Liu, Shu Zhang, Yuan Chen
Evaluation of Bottom-up Modeling of the Blood-Brain Barrier to Improve Brain Penetration Prediction via Physiologically Based Pharmacokinetic Modeling. Biopharmaceutics & drug disposition (2023)